First in Class Drug for Diabetes enters Phase 2b Clinical Testing. Metabasis announced that MB07803 which is designed to regulate glucose production in the liver by inhibiting an enzyme known as fructose 1,6- bisphosphatase (FBPase), a key component of the gluconeogenesis pathway is starting clinical trials. This means yet another …

It is this time of year when you think of family and old friends, and your thoughts might turn to places you used to live or where you went to college. Well my college town made the headlines last week as America’s Fattest And Unhealthiest City.

Charcot Foot: A Potential Risk Factor for Diabetic Patients, is a valuable report on an under diagnosed problem written by Jennifer Webb, Doctor of Pharmacy Candidate, FAMU. You may want to print this out and hand it to your patients.

An assessment tool known as Tool to Assess Likelihood of Fasting Glucose ImpairmenT (TAG-IT) is effective in screening patients of varying ethnic backgrounds for prediabetes, according to the results of a new study. Researchers say the test is an improvement over using BMI alone or using a list of risk …

Treatment with cholesterol-lowering rosuvastatin reduced coronary events by 44% — including overall mortality — among patients who are asymptomatic for heart disease but have high levels of high-sensitivity C-reactive protein and low levels of low-density lipoprotein (LDL) cholesterol.

Twice as many older Americans are hospitalized with heart failure than 25 years ago, reflecting an aging population and success in keeping people alive after heart attacks and disease damage the organ, researchers said.

High-sensitivity C-reactive protein modestly improves prediction of global cardiovascular risk beyond traditional risk factors, according to two longitudinal studies.

Generex announces a partnership with a company to promote their oral insulin with more than a 1000 person sales force in India.

Drug-coated stents appear to be superior to bare metal stents in both efficacy and safety in patients with diabetes, new research shows.

A large waist circumference is related to a higher risk of death even for individuals who have the same BMI [body mass index, a ratio of weight to height].